SANTA CLARA, Calif. — Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. The Company expects to report cash-on-hand of at least $38 million as of March 31, 2013. […]
WALTHAM, Mass — At the American Association for Cancer Research 2013 Annual Meeting (Booths 1513, 1424) PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will showcase a full suite of solutions designed to accelerate cancer research. The Company will introduce an expanded portfolio of assays, informatics […]
PORT WASHINGTON, N.Y., – Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today confirmed plans for a state-of–the-art Life Sciences Centre of Excellence at its new Harbourgate site in Portsmouth in the United Kingdom (UK). The Centre of Excellence (COE), which will open in mid 2013, will offer a full suite of […]
NORTH BRUNSWICK, NJ, – Hurel Corporation (“Hurel”), a worldleading provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms that improve the predictive reliability and over-all efficiency of preclinical drug development, today announced that Spring Mountain Capital has organized and closed a $9.2 million Series A private equity financing facility for the Company. Funds […]
SAN DIEGO, CA – Genalyte, Inc. today announced the launch of its MT-ADATM anti-drug antibody (ADA) immunogenicity assay designed to run on the MaverickTM Detection System. This test combines screening for the presence of ADAs and the characterization of each detected ADA with a full isotype profile. With minimal required sample preparation and its combination […]
Jena (Germany), – Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) has with the approval of the Supervisory Board today signed a contract for the acquisition of all shares of UVP, LLC, incorporated under US law as a limited liability company, based in Upland/California, USA. Upon the transfer of the shares for purposes of the […]
PORT WASHINGTON, N.Y., – Pall Corporation (NYSE: PLL) today announced that its board of directors will appoint Akhil Johri as Chief Financial Officer (CFO), effective May 1, 2013. Mr. Johri, 51, is currently Vice President of Finance and Chief Financial Officer for United Technologies Corporation’s (UTC) Propulsion & Aerospace Systems group, a $27 billion unit […]
Genalyte Announces CE Mark for Maverick TM Detection System and Signs On First European Distributors
SAN DIEGO, CA –– Genalyte, Inc. today announced its MaverickTM Detection System that simultaneously analyzes multiple antibodies and other proteins from a single small sample is now CE marked in Europe for research use. The company also reported its first European distribution agreements for the Maverick Detection System, signing on specialty distributors Mokascience in France, […]
Singapore,– Pall Filtration Pte Ltd, the Asia-Pacific headquarters of Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, will be collaborating with Nanyang Polytechnic (NYP) School of Chemical & Life Sciences (SCL) to develop talent for the rapidly growing biologics sector within Singapore’s S$13 billion pharmaceutical industry. The three-year collaboration encompasses student […]
SAN DIEGO, — BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of two new leases for 15 years with Life Technologies Corporation (NASDAQ: LIFE) at its Science Center at Oyster Point property in the heart of the South San Francisco, California life science submarket. Life Technologies, a global biotechnology company, will fully occupy […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
